explain glp-1 What is and Its Receptor Agonists? GLP-1 and the kidney: from

Description

In an update posted on its website on 2 January 2024, the US FDA confirmed that it was carrying out the []

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

This innovative oral GLP-1 is a small molecule medication that, unlike the Wegovy pill, doesnt require that you take it on an empty stomach.

community on Amazon, Instagram, TikTok, Facebook

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways